PMDA drug package insert
ヨンデリス点滴静注用0.25mg
PMDA Prescription drug · 大鵬薬品工業株式会社 · package insert Jun 11, 2024
Key facts
| Brand names | ヨンデリス点滴静注用0.25mg, ヨンデリス点滴静注用1mg |
|---|---|
| Nonproprietary names | トラベクテジン |
| Companies | 製造販売元／大鵬薬品工業株式会社, 提携先／Pharma Mar, S.A. |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291431D1027, 4291431D2023 |
| Approval numbers | 22700AMX01019000, 22700AMX01020000 |
| Package insert edition | 第2版 |
| Package insert date | Jun 11, 2024 |
| PMDA document key | 400107_4291431D1027_1 |
| PMDA company code | 400107 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: